Coronary heart disease mortality in treated familial hypercholesterolaemia: Update of the UK Simon Broome FH register

BACKGROUND AND AIMS: Patients with familial hypercholesterolaemia (FH) have an elevated risk of coronary heart disease (CHD). Here we compare changes in CHD mortality in patients with heterozygous (FH) pre 1992, before lipid-lowering therapy with statins was used routinely, and in the periods 1992–2008 and 2008–2016. METHODS: 1903 Definite (DFH) and 1650 Possible (PFH) patients (51% women) aged 20–79 years, recruited from 21 lipid clinics in the United Kingdom and followed prospectively between 1980 and 2016 for 67,060 person-years. The CHD standardised mortality ratio (SMR) compared to the po... Mehr ...

Verfasser: Humphries, SE
Cooper, JA
Seed, M
Capps, N
Durrington, PN
Jones, B
McDowell, IFW
Soran, H
Neil, HAW
Dokumenttyp: Artikel
Erscheinungsdatum: 2018
Verlag/Hrsg.: ELSEVIER IRELAND LTD
Schlagwörter: Heterozygous familial hypercholesterolemia / Coronary mortality / Cancer mortality / Dutch lipid clinic network score
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-26663548
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://discovery.ucl.ac.uk/id/eprint/10054723/1/Humphries_Coronary%20heart%20disease%20mortality%20in%20treated%20familial%20hypercholesterolaemia.%20Update%20of%20the%20UK%20Simon%20Broome%20FH%20register_VoR.pdf